Advanced search
Publication Cover
Acta Orthopaedica Volume 90, 2019 - Issue 4
Journal homepage
2,659
Views
8
CrossRef citations to date
0
Altmetric
Articles

Optimal duration of anticoagulant thromboprophylaxis in total hip arthroplasty: new evidence in 55,540 patients with osteoarthritis from the Nordic Arthroplasty Register Association (NARA) group

Alma B PedersenDepartment of Clinical Epidemiology, Aarhus University Hospital, Denmark; Correspondence[email protected]
,
Ina Trolle AndersenDepartment of Clinical Epidemiology, Aarhus University Hospital, Denmark;
,
Soren OvergaardDepartment of Orthopaedic Surgery and Traumatology, Odense University Hospital, Department of Clinical Research, University of Southern Denmark, Odense, Denmark;
,
Anne Marie FenstadThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway;
,
Stein Atle LieDepartment of Clinical Medicine, University of Bergen, Norway; ;Department of Clinical Dentistry, University of Bergen, Bergen, Norway
,
Jan-Erik GjertsenThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway; ;Department of Clinical Medicine, University of Bergen, Norway;
&
Ove FurnesThe Norwegian Arthroplasty Register, Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway; ;Department of Clinical Medicine, University of Bergen, Norway;
show all
Pages 298-305 | Published online: 07 May 2019

  • Adelborg K, Sundboll J, Munch T, Froslev T, Sorensen H T, Botker H E, Schmidt S. Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study. BMJ Open 2016; 6: e012817.
  • Anderson D R, Dunbar M, Murnaghan J, Kahn S R, Gross P, Forsythe M, Pelet S, Fisher W, Belzile E, Dolan S, Crowther M, Bohm E, MacDonald S J, Gofton W, Kim P, Zukor D, Pleasance S, Andreou P, Doucette S, Theriault C, Abianui A, Carrier M, Kovacs M J, Rodger M A, Coyle D, Wells P S, Vendittoli P A. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med 2018; 378: 699–707.
  • Arthursson A J, Furnes O, Espehaug B, Havelin L I, Soreide J A. Validation of data in the Norwegian Arthroplasty Register and the Norwegian Patient Register: 5,134 primary total hip arthroplasties and revisions operated at a single hospital between 1987 and 2003. Acta Orthop 2005; 76: 823–8.
  • Azboy I, Barrack R, Thomas A M, Haddad F S, Parvizi J. Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions. Bone Joint J 2017; 99-B: 1420–30.
  • Bakken I J, Nyland K, Halsteinli V, Kvam U H, Skjeldestad F E. Norsk pasientregister: Administrativ database med mange forskningsmuligheter. Norsk Epidemiologi 2004; 14: 65–9.
  • Borgen P O, Pripp A H, Dybvik E, Leistad L, Dahl O E, Reikeras O. Similar clinical outcomes with preoperative and postoperative start of thromboprophylaxis in THA: a register-based study. Clin Orthop Relat Res 2017; 475: 2245–52.
  • Budhiparama N C, Abdel M P, Ifran N N, Parratte S. Venous thromboembolism (VTE) prophylaxis for hip and knee arthroplasty: changing trends. Curr Rev Musculoskelet Med 2014; 7: 108–16.
  • Danish Council for the Use of Expensive Hospital Medicine (RADS) Baggrundsnotat: Tromboseprofylakse til ortopaedkirurgiske patienter; 2016. https://rads.dk/media/2086/lmr-tromboseprofylakse-knae-og-hoftekirurgi-marts-2016.pdf
  • Eikelboom J W, Quinlan D J, Douketis J D. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 2001; 358: 9–15.
  • Falck-Ytter Y, Francis C W, Johanson N A, Curley C, Dahl O E, Schulman S, Ortel T L, Pauker S G, Colwell C W. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed., American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e278S–e325S.
  • Forster R, Stewart M. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. Cochrane Database Syst Rev 2016; 3: CD004179.
  • Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD)—new opportunities for research in pharmacoepidemiology in Norway. Norsk Epidemiologi 2008; 18: 129–36.
  • Gomez D, Razmjou H, Donovan A, Bansal V B, Gollish J D, Murnaghan J J. A phase IV study of thromboembolic and bleeding events following hip and knee arthroplasty using oral Factor Xa inhibitor. J Arthroplasty 2017; 32: 958–64.
  • Granan L P. Prevention of VTE in orthopedic surgery patients: a Norwegian adaptation of the 9th ed. of the ACCP Antithrombotic Therapy and Prevention of Thrombosis Evidence-based Clinical Practice Guidelines. Norsk Selskap for Trombose og Hemostase; 2015.
  • Hull R D, Pineo G F, Stein P D, Mah A F, MacIsaac S M, Dahl O E, Butcher M, Brant R F, Ghali W A, Bergqvist D, Raskob G E. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001; 135: 858–69.
  • Huo M H. Post-discharge venous thromboembolism and bleeding in a large cohort of patients undergoing total hip or total knee arthroplasty. J Clin Outcomes Management 2012; 19: 355–63.
  • Johannesdottir S A, Horvath-Puho E, Ehrenstein V, Schmidt M, Pedersen L, Sorensen H T. Existing data sources for clinical epidemiology: the Danish National Database of Reimbursed Prescriptions. Clin Epidemiol 2012; 4: 303–13.
  • Nemes S, Gordon M, Rogmark C, Rolfson O. Projections of total hip replacement in Sweden from 2013 to 2030. Acta Orthop 2014; 85: 238–43.
  • O’Donnell M, Linkins L A, Kearon C, Julian J, Hirsh J. Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty: a systematic review. Arch Intern Med 2003; 163(11): 1362–6.
  • Pedersen A, Johnsen S, Overgaard S, Soballe K, Sorensen H, Lucht U. Registration in the Danish Hip Arthroplasty Registry: completeness of total hip arthroplasties and positive predictive value of registered diagnosis and postoperative complications. Acta Orthop Scand 2004; 75(4): 434–41.
  • Pedersen A B, Johnsen S P, Sorensen H T. Increased one-year risk of symptomatic venous thromboembolism following total hip replacement: a nationwide cohort study. J Bone Joint Surg Br 2012; 94: 1598–1603.
  • Pedersen A B, Sorensen H T, Mehnert F, Johnsen S P, Overgaard S. Efficacy and safety of short and extended thromboprophylaxis in 16,865 unselected hip replacement patients from routine clinical practice. Thromb Res 2015; 135(2): 322–8.
  • Pedersen A B, Ehrenstein V, Szepligeti S K, Sorensen H T. Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity. Osteoporos Int 2017; 28(12): 3421–30.
  • Petersen P B, Kehlet H, Jorgensen C C. Lundbeck Foundation Centre for Fast-track & G. Knee Replacement Collaborative. Safety of in-hospital only thromboprophylaxis after fast-track total hip and knee arthroplasty: a prospective follow-up study in 17,582 procedures. Thromb Haemost 2018; 118(12): 2152–61.
  • Sayers A, Evans J T, Whitehouse M R, Blom A Q. Are competing risks models appropriate to describe implant failure? Acta Orthop 2018; 89: 256–8.
  • Schmidt M, Pedersen L, Sorensen H T. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 2014; 29: 541–9.
  • Schmidt M, Schmidt S A, Sandegaard J L, Ehrenstein V, Pedersen L, Sorensen H T. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol 2015; 7: 449–90.
  • Sobieraj D M, Lee S, Coleman C I, Tongbram V, Chen W, Colby J, Kluger J, Makanji S, Ashaye A O, White C M. Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review. Ann Intern Med 2012; 156: 720-7.
  • Sundboll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 2016; 6(11): e012832.
  • Thygesen S K, Christiansen C F, Christensen S, Lash T L, Sorensen H T. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83.
  • Trevisol A R, Coppi E F M, Pancotte J, Bortoluzzi E C, Knop G P. Use of oral anticoagulants for the prevention of thromboembolic events in the post-operative period of hip arthroplasty: a systematic review. Rev Bras Ortop 2018; 53(5): 515–20.
  • Wolf B R, Lu X, Li Y, Callaghan J J, Cram P. Adverse outcomes in hip arthroplasty: long-term trends. J Bone Joint Surg Am 2012; 94: e103.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.